Trial Summary Table

Trial Name	Phase	Start Date	Sponsors	Countries	Population	Candidate(s)	Status	Expected Completion Date
MTN-044/IPM 053/ CCN019	Open Label, I	Tuesday, July 17, 2018		United States of America	Women	Dapivirine-Levonorgestrel ring	Completed	October 2019
NNRTI Microbicide Gel	I	Monday, March 31, 2014	Population Council, USAID	United States of America	Women	PC-1005 gel, HEC gel	Completed	March 2015
Novel mAb contraceptive + TDF IVR	Pre-clinical	Saturday, May 2, 2020	NICHD			TDF	Ongoing	February 2021
OB-002H	I	Saturday, October 5, 2019	SCOPE International AG	Poland	MSM, Women		Completed	August 2020
Pop Council PC-6500 Vaginal insert	I	Thursday, March 1, 2018			Women	PC-6500		July 2018
Population Council #558	I	Friday, May 2, 2014	Population Council	United States of America	Women	PC-1005 gel, HEC gel	Completed	June 2015
Population Council #728	I	Friday, October 6, 2017		United States of America	Women	PC-6500	Completed	September 2018
POWER	Demo Project	Wednesday, June 14, 2017	University of Washington ICRC, Carnegie Mellon University, DTHF, Harvard U., KEMRI, Massachusetts General Hospital, RTI, Wits RHI, USAID	South Africa, Kenya	Women	TDF/FTC (Truvada), TVF/FTC	Ongoing	June 2021
Pre-exposure prevention of viral entry (PREVENT)	Pre-clinical	Saturday, January 11, 2014	NIH, NIAID	United States of America		GRFT		March 2019
PREVENT study	I	Wednesday, July 10, 2019	Rhonda Brand; NIAID; Intrucept Biomedicine LLC		Men, Women	Q-GRFT		February 2021

You are here